New weapon against tough cancers enters human testing
NCT ID NCT05547321
Summary
This is a first-in-human study to find a safe dose of a new experimental drug called OMTX705 for patients with advanced solid tumors that have stopped responding to standard treatments. The trial will test OMTX705 by itself and combined with existing immunotherapy drugs. The main goal is to understand the drug's safety and side effects, while also looking for early signs that it might help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
-
Clínica Universitaria de Navarra
RECRUITINGPamplona, Navarre, Spain
Contact
-
Hospital 12 Octubre
RECRUITINGMadrid, Madrid, Spain
Contact
-
Hospital Clínico Universitario de Santiago
NOT_YET_RECRUITINGSantiago de Compostela, Galicia, 15706, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital MD Anderson
RECRUITINGMadrid, Madrid, Spain
Contact
-
Hospital Universitari Vall d'Hebron
NOT_YET_RECRUITINGBarcelona, Barcelona, Spain
Contact
-
Hospital Universitario de Donostia
RECRUITINGSan Sebastián, Guipúzcoa, Spain
Contact
-
ICO L'Hospitalet
RECRUITINGL'Hospitalet de Llobregat, Barcelona, Spain
Contact
-
Onkologikoa
RECRUITINGSan Sebastián, Spain
Contact
Conditions
Explore the condition pages connected to this study.